When TLR2 was absent from mice implanted with GL261 glioma cells, the tumors were significantly smaller, the expression of membrane type 1 matrix metalloprotease (MT1-MMP) was decreased, and the survival rates were higher than in wild-type control mice. This evidence concerns the gene MMP14 and central nervous system cancer.